Riskpilot← Back to searchSign inGet full accessVESTERELVA LEGESENTER AS
ASActiveOrg 928054616Dokka 6, 1671 KråkerøyGeneral medical practice activities · NACE 8621Est. 20213 employees
Revenue 2024
NOK 4,4M
+11% vs 2023
EBITDA margin
5.4%
+138% vs 2023
Equity ratio
51.6%
Financial strength
Net profit 2024
NOK 113K
+439% vs 2023
| Revenue | NOK 4,4M | +11% |
| EBITDA | NOK 234K | +138% |
| Net profit | NOK 113K | +439% |
| Total assets | NOK 885K | +4% |
| Equity | NOK 457K | +33% |
| Employees | 3 | — |
Legal name
VESTERELVA LEGESENTER AS
Org number
928054616
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
3. november 2021
Share capital
NOK 30 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Company purpose
På forretningsmessig forsvarlig måte drive helsetjeneste, samt salg av tjenester for legevirksomhet og tilrettelegging for annen praksis, import, agentur, salg, forskning, informasjon, undervisning/kursarrangement og konsulentvirksomhet, investering og utleie, deltagelse i annen praksis og beslektet virksomhet.
Address
Dokka 6, 1671 Kråkerøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 299 | 3 745 | 3 928 | 4 358 |
| Staff expenses | −143 | −1 554 | −1 721 | −1 772 |
| EBITDA | 8 | 233 | 98 | 234 |
| Depreciation & amort. | −3 | −69 | −72 | −91 |
| EBIT | 5 | 164 | 27 | 143 |
| Net financials | 0 | −0 | 1 | 2 |
| Profit before tax | 5 | 164 | 28 | 145 |
| Tax | −0 | 35 | 7 | 32 |
| Net profit | 5 | 129 | 21 | 113 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 461 | 810 | 852 | 885 |
| Equity | 195 | 323 | 344 | 457 |
| Long-term debt | 0 | 11 | 9 | 2 |
| Short-term debt | 267 | 475 | 499 | 426 |
| Total debt | 267 | 486 | 508 | 428 |
EBITDA margin
5.4%
This company
15.8%
Market median
-66% vs market
20212024
Equity ratio
51.6%
This company
38.2%
Market median
+35% vs market
20212024
Return on equity
24.7%
This company
18.4%
Market median
+34% vs market
20212024
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20212024
Asset turnover
4.92×
This company
1.12×
Market median
+339% vs market
20212024
Debt / equity
0.94×
This company
0.62×
Market median
+52% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KL Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VESTERELVA LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karoline Lund | Chief Executive Officer | 0 companies |
| Bjørn-Tore Martinussen | Board of Directors | 0 companies |
| Hanne Sigrid Tolfsen | Board of Directors | 0 companies |
| Ena Nielsen | Board of Directors | 0 companies |